DiscoverAuthor: Tiphaine Di Valentin
Publications
Breast Cancer
A platform of metastatic bioluminescent PDX: Focus on HBCx14-Luc1 metastatic bioluminescent breast tumorgraft model for preclinical studies
Discover
Publications
Breast Cancer
Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments
Discover
Publications
Breast Cancer
XenTech patient-derived xenograft (PDX) panels: a clinically relevant platform for drug efficacy, target validation and predictive biomarker discovery studies
Discover
Publications
Breast Cancer
The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
Discover
Publications
Breast Cancer
Understanding breast cancer resistance to chemotherapy: Characterization of cancer cell sub-populations in residual and relapsed tumors
Discover
Publications
Breast Cancer
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features
Discover
Publications
Breast Cancer
Cell-autonomous activation of the Interferon/STAT1 pathway in response to genotoxic treatment
Discover
Publications
Breast Cancer
Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer
Discover
Publications
Breast Cancer
MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC
Discover